Risk & Leverage

Erasca reports promising early data for its pan-RAS inhibitor, ERAS-0015, showing tumor shrinkage at low doses and shaking up the competitive landscape.

Recent findings of bacteria and heavy metals in baby formula have parents worried and legal experts demanding greater manufacturer accountability.

Facing a Nasdaq delisting notice, social commerce firm Webuy Global has 45 days to devise a plan to fix its $2.1M stockholders' equity deficiency.

The fast-food giant makes a significant debt repayment as part of its 'JACK on Track' plan, signaling a strategic pivot to fix its balance sheet.

Promising Phase 2 data shows a new DNA immunotherapy for advanced melanoma, delivered via a needle-free jet injector, significantly improves patient outcomes.

Health Canada uncovers counterfeit erectile dysfunction drugs in Mississauga, warning of life-threatening dangers and a compromised supply chain.

The oil and gas firm raised its quarterly payout to $0.40/share, rewarding investors and underscoring its financial health and disciplined strategy.

Koppers Holdings navigates a key leadership change as CFO Jimmi Sue Smith retires. Veteran Bradley Pearce takes the helm as interim financial chief.

Facing a Nasdaq delisting notice, Chinese office provider Ucommune plans drastic measures amid dire financials and a saturated real estate market.

After its stock soared on a Starlink deal, private jet operator flyExclusive announced a public offering, balancing growth ambitions with market risk.

A new study on oral testosterone therapy for men 65-80 could reshape geriatric care, challenge FDA guidelines, and unlock a multi-billion dollar market.

Luxury brand owner Tapestry partners with Pivot Energy on Illinois solar projects, powering homes and funding new green job training programs for locals.

A European deep-tech firm emerges from stealth with a system that powers moving and rotating devices, aiming to untether robotics and spatial computing.

The software giant is launching AI-powered AP automation, mobile payments, and integrated financing to tackle contractor cash flow and operational headaches.

Azafaros presents its promising drug, nizubaglustat, for untreatable rare neurological disorders, backed by major funding and late-stage clinical trials.

With its CEO stepping down, Lifeist Wellness tasks its CFO with a dual role, signaling a push for stability as it navigates a tough market.

A new partnership offers Hawaiians free e-waste recycling, Sony Open tickets, and a chance to help restore the Ala Wai Canal this weekend.

For the third straight year, WesBanco is named a top regional bank by Newsweek, a nod to its financial health, deep community roots, and customer trust.

Bank7 Corp. is set to reveal its 2025 results. With a strong track record and new acquisitions, will it beat expectations amid a mixed regional economy?

Following a pivotal 2024 merger, California BanCorp appoints veteran banker and Chairman David Rainer as CEO, succeeding the retiring Steven Shelton.